Kory McDonald is Vice President and Head, Market Access and Government Affairs at Bayer Inc. In this role she leads Bayer’s patient support, pricing, market access and government affairs functions and is a member of Bayer’s Pharmaceutical Leadership Team. Since joining Bayer in 2007 as Director of Federal Government Affairs, Kory has held several roles and worked in diverse therapeutic areas, including oncology, hematology, ophthalmology, women’s health and cardiology.
Prior to joining Bayer, Kory was AVP Legislative Relations at the Canadian Life and Health Insurance Association. Kory holds a Masters in Comparative Politics from the University of Cape Town in South Africa.
Day 1: Oct 6, 2020
Strategies for Managing Through the Adjusted Timeline and Transition to Implementation of the New Pricing Guidelines
Given the uncertainties created by the change in implementation date to the new pricing guidelines, navigating the marketplace will be challenging. Fine-tune your pricing strategy as the new guidelines gain clarity. Take away a road map to help your organization with:
- Strategies for product positioning and pricing
- Insights about determining factors on whether medicines will be classified as Category I or Category II
- Understanding what impact the current consultation process could have on the final guidelines and on your organization
Gain clarity on how to align your pricing strategies with the new PMPRB pricing guidelines as they emerge under the new implementation timeline
Day 2: Oct 7, 2020
Day 3: Oct 8, 2020